New CEOs bring financial savvy to Canopy Growth, Medicine Man Technologies

It’s Day One of?the Investor Intelligence Conference in Las Vegas, but we wanted to highlight two news pieces out this morning that directly support our main theme:

The cannabis industry needs to improve capital return analysis and investor communication to public company standards if it is to successfully raise capital, as it is increasingly normalizing and competing for capital against traditional public companies industries.

Canopy Growth has a new CEO in David Klein,?who was the CFO of Constellation Brands, and Medicine Man Technologies has a new CEO in Justin Dye,?the major outside investor in the company.

Both of these individuals have extensive financial and capital raising experience that should serve both companies well.

 

Read Now

Sign inJoin for instant access